| Tenofovir versus entecavir for hepatocellular carcinoma prevention in an international consortium of chronic hepatitis B YC Hsu, GLH Wong, CH Chen, CY Peng, ML Yeh, KS Cheung, H Toyoda, ... Official journal of the American College of Gastroenterology| ACG 115 (2 …, 2020 | 93 | 2020 |
| Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues TY Jang, YJ Wei, TW Liu, ML Yeh, SF Liu, CT Hsu, PY Hsu, YH Lin, ... Scientific Reports 11 (1), 8184, 2021 | 30 | 2021 |
| Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients TY Jang, PC Lin, CI Huang, YM Liao, ML Yeh, YS Zeng, PC Liang, ... PloS one 12 (6), e0178883, 2017 | 28 | 2017 |
| Association of hyperuricemia with disease severity in chronic hepatitis C patients TY Jang, ML Yeh, CI Huang, ZY Lin, SC Chen, MH Hsieh, CY Dai, ... PloS one 13 (11), e0207043, 2018 | 24 | 2018 |
| Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan MY Lu, CT Chen, YL Shih, PC Tsai, MH Hsieh, CF Huang, ML Yeh, ... Scientific reports 11 (1), 8554, 2021 | 22 | 2021 |
| Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort CF Huang, TY Jang, PH Wu, MC Kuo, ML Yeh, CW Wang, PC Liang, ... Virology Journal 20 (1), 112, 2023 | 17 | 2023 |
| Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis PY Hsu, YJ Wei, JJ Lee, SW Niu, JC Huang, CT Hsu, TY Jang, ML Yeh, ... Clinical and Molecular Hepatology 27 (1), 186, 2021 | 15 | 2021 |
| On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients CF Huang, TY Jang, DW Jun, SB Ahn, J An, M Enomoto, H Takahashi, ... Liver International 42 (1), 59-68, 2022 | 14 | 2022 |
| Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication MY Lu, ML Yeh, CI Huang, SC Wang, YS Tsai, PC Tsai, YM Ko, CC Lin, ... World Journal of Gastroenterology 28 (1), 140, 2022 | 14 | 2022 |
| Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison CT Chen, MY Lu, MH Hsieh, PC Tsai, TY Hsieh, ML Yeh, CI Huang, ... World Journal of Gastroenterology 28 (2), 263, 2022 | 13 | 2022 |
| Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan PC Tsai, CI Huang, ML Yeh, CF Huang, MH Hsieh, JF Yang, PY Hsu, ... BMJ open 11 (3), e042861, 2021 | 13 | 2021 |
| Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues TY Jang, YJ Wei, ML Yeh, SF Liu, CT Hsu, PY Hsu, TW Liu, YH Lin, ... Journal of the Formosan Medical Association 120 (1), 303-310, 2021 | 13 | 2021 |
| Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents TY Jang, CI Huang, ML Yeh, PC Liang, PC Tsai, YH Lin, MY Hsieh, ... Journal of Gastroenterology and Hepatology 35 (3), 473-481, 2020 | 11 | 2020 |
| Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels PY Hsu, TS Cheng, SC Chuang, WT Chang, PC Liang, CT Hsu, YJ Wei, ... Cancer Medicine 11 (1), 104-116, 2022 | 10 | 2022 |
| Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study CI Shih, KT Wu, MH Hsieh, JF Yang, YY Chen, WL Tsai, WC Chen, ... Hepatology International 18 (1), 138-154, 2024 | 9 | 2024 |
| Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication MY Lu, TW Liu, PC Liang, CI Huang, YS Tsai, PC Tsai, YM Ko, WH Wang, ... American Journal of Cancer Research 13 (1), 190, 2023 | 9 | 2023 |
| Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma PY Hsu, PC Liang, WT Chang, MY Lu, WH Wang, SC Chuang, YJ Wei, ... American Journal of Cancer Research 12 (12), 5576, 2022 | 9 | 2022 |
| The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis TY Jang, CI Huang, ML Yeh, ZY Lin, SC Chen, WL Chuang Medicine 98 (13), e15066, 2019 | 9 | 2019 |
| Community-centered disease severity assessment of metabolic dysfunction-associated fatty liver disease JF Huang, PC Tsai, ML Yeh, CF Huang, CI Huang, MH Lee, PY Hsu, ... Journal of Clinical and Translational Hepatology 11 (5), 1061, 2023 | 8 | 2023 |
| Liver injury caused by SARS-CoV-2 Delta and Omicron-variant in Taiwan TY Jang Journal of the Formosan Medical Association 121 (11), 2367, 2022 | 8 | 2022 |
